Björn has 27 years of experience in academia and industry. Before joining Eleva, he acquired ample know-how, spanning R&D, strategy, and business development, while working at several prestigious scientific institutions and enterprises. Björn’s career has included positions at the German Cancer Research Institute (DKFZ), where he headed the Department for Recombinant Antibodies, Affitech, where he was the Head of R&D, Roche, where he served as Director of Business Development, and Ciliatech, where he was an Interim CEO. Björn also had several opportunities to contribute his expertise to reputable companies in Asia, including as Head of Oncology at Otsuka NP in Munich, Germany and Tokyo, Japan and Head Development for Japan-Asia-Pacific AbbVie in Singapore. Björn is a Co-Founder of Medraxa Therapeutics in Heidelberg and he has also served as a Chairman for numerous companies, including Sapreme in Utrecht and Karolinska Development in Stockholm.